Need help? Our team of experienced experts is here for you with full support.
AKA-25
Betuak® Betulinic Acid
Cat. No.
AKA-25
CAS No.
472-15-1
MF
C30H48O3
MW
456.7003
Betuak® Betulinic acid is a natural pentacyclic lupane-type triterpene, an inhibitor of eukaryotic topoisomerase I.
Advanced Equipments & Extensive Production Expertise
Commercial Manufacturing
Stable Quality
Customization Supporting
Technical Data
Description
Documents
Storage and Shipping
References
Product Name
Betuak® Betulinic Acid
CAS No.
472-15-1
MF
C30H48O3
MW
456.7003
Specification
98%
Research Area
Antiretroviral, antimalarial, and anti-inflammatory
Description
Betuak® Betulinic acid is a natural pentacyclic lupane-type triterpene, an inhibitor of eukaryotic topoisomerase I. Packing: 1kg/bag; 25kg/drum or as request Availability: In stock
Documents
Can't find the right version? Our team of experienced experts is here for you with full support.Contact Us
Storage and Shipping
Store in a cool & dry place, keep away from strong light and heat.
References
[1]. Chowdhury AR, et al. Betulinic acid, a potent inhibitor of eukaryotic topoisomerase I: identification of the inhibitory step, the major functional group responsible and development of more potent derivatives. Medical Science Monitor. 2002 Jul;8(7):BR254-65.
[2]. Gao Y, et al. Betulinic acid induces apoptosis and ultrastructural changes in MDA-MB-231 breast cancer cells. Ultrastructural Pathology. 2018 Jan-Feb;42(1):49-54.
[3]. Kalra J, et al. Betulinic acid alleviates dextran sulfate sodium-induced colitis and visceral pain in mice. Naunyn-Schmiedeberg's Archives of Pharmacology. 2017 Dec 26.
[4]. Hashimoto F, et al. Anti-AIDS agents--XXVII. Synthesis and anti-HIV activity of betulinic acid and dihydrobetulinic acid derivatives. Bioorganic & Medicinal Chemistry. 1997 Dec;5(12):2133-43.
[5]. Kasperczyk H, et al. Betulinic acid as new activator of NF-kappaB: molecular mechanisms and implications for cancer therapy. Oncogene. 2005 Oct 20;24(46):6945-56.
[6]. Fernandes S, et al. Betulinic Acid for Glioblastoma Treatment: Reality, Challenges and Perspectives. International Journal of Molecular Sciences. 2024 Feb 9;25(4):2108.
Related Products
* Some statements have not been evaluated by national authorities. * Some products are not intended to diagnose, treat, cure, or prevent any disease. * For literature supporting, please contact us directly.